
### [NCIT:C4450](http://purl.obolibrary.org/obo/NCIT_C4450)
**Label:** Large Cell Lung Carcinoma

**Subclasses:** [NCIT:C8755](http://purl.obolibrary.org/obo/NCIT_C8755) (Stage I Large Cell Lung Carcinoma AJCC v7), [NCIT:C8756](http://purl.obolibrary.org/obo/NCIT_C8756) (Stage IV Large Cell Lung Carcinoma AJCC v7), [NCIT:C6876](http://purl.obolibrary.org/obo/NCIT_C6876) (Large Cell Lung Carcinoma with Rhabdoid Phenotype), [NCIT:C7267](http://purl.obolibrary.org/obo/NCIT_C7267) (Combined Large Cell Lung Neuroendocrine Carcinoma), [NCIT:C8753](http://purl.obolibrary.org/obo/NCIT_C8753) (Recurrent Large Cell Lung Carcinoma), [NCIT:C7266](http://purl.obolibrary.org/obo/NCIT_C7266) (Basaloid Large Cell Lung Carcinoma), [NCIT:C4451](http://purl.obolibrary.org/obo/NCIT_C4451) (Large Cell Lung Carcinoma, Clear Cell Variant), [NCIT:C5672](http://purl.obolibrary.org/obo/NCIT_C5672) (Large Cell Lung Neuroendocrine Carcinoma), [NCIT:C9257](http://purl.obolibrary.org/obo/NCIT_C9257) (Stage III Large Cell Lung Carcinoma AJCC v7), [NCIT:C6660](http://purl.obolibrary.org/obo/NCIT_C6660) (Stage II Large Cell Lung Carcinoma AJCC v7), [NCIT:C136493](http://purl.obolibrary.org/obo/NCIT_C136493) (Large Cell Lung Carcinoma by AJCC v7 Stage), [NCIT:C45519](http://purl.obolibrary.org/obo/NCIT_C45519) (Lymphoepithelioma-Like Lung Carcinoma), [NCIT:C35758](http://purl.obolibrary.org/obo/NCIT_C35758) (Stage 0 Large Cell Lung Carcinoma AJCC v6 and v7), 

**Class expressions from DL-Learner:**

- Thing 53.84%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 37.53%


